Press-release for stocks for bristol-myers squibb company

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Bristol-myers squibb company crawled time : 20:00

save search

Pomerantz Law Firm Announces the Filing of a Class Action Against VinFast Auto Ltd. and Certain Officers - VFS
Published: 2024-04-12 (Crawled : 20:00) - prnewswire.com
FICO S | $1162.25 0.78% -0.2% 180K

|

Technology Services

| Email alert Add to watchlist
VFS | $2.71 -0.37% -0.74% 2.4M

|

| Email alert Add to watchlist
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| Email alert Add to watchlist
BSAQ | $10.2 2.45% 380

|

| Email alert Add to watchlist

FDA Roundup: March 8, 2024
Published: 2024-03-08 (Crawled : 20:00) - prnewswire.com
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| Email alert Add to watchlist
fda

Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published: 2024-02-29 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40

|

Health Technology

| -3.76% | O: -2.33% H: 3.68% C: 2.44%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -7.38% | O: 0.89% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -7.81% | O: 1.03% H: 0.14% C: 0.05%
JNJ | News | $145.74 0.67% -0.18% 7M

|

Health Technology

| -10.18% | O: 0.28% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M

|

Health Technology

| -5.49% | O: 0.26% H: 0.18% C: 0.05%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -4.83% | O: 0.37% H: 0.27% C: -0.1%
integration reach momentum infection treatment market

Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published: 2024-02-12 (Crawled : 20:00) - prnewswire.com
ALPMY | $9.47 0.11% -1.11% 520K

|

| -13.68% | O: 0.37% H: 0.74% C: 0.28%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -2.91% | O: -0.18% H: 0.48% C: -1.91%
ABBV | News | $164.66 0.25% -0.14% 3.6M

|

Health Technology

| -4.57% | O: 0.8% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

|

Health Technology

| -1.49% | O: -0.06% H: 0.0% C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 4.9M

|

Health Technology

| -10.14% | O: 0.32% H: 0.11% C: -1.55%
ALNY | News | $145.16 -0.11% -0.19% 400K

|

Health Technology

| -14.28% | O: -2.63% H: 0.98% C: -1.75%
liver disease therapeutics market

PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
Published: 2023-12-22 (Crawled : 20:00) - biospace.com/
PTCHF | $2.78 19.97% 560

|

| 48.35% | O: 29.67% H: 0.0% C: -5.76%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -5.77% | O: -0.78% H: 5.15% C: 2.81%
KRTX | $329.83 0.0% 1.9M

|

Health Technology

| 53.27% | O: 47.74% H: 0.0% C: 0.0%
therapeutics acquired

Avidity Biosciences Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb for up to Five Targets Utilizing Avidity's Proprietary AOC™ Platform Technology
Published: 2023-11-28 (Crawled : 20:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -1.47% | O: 0.06% H: 0.55% C: -0.27%
RNA | $23.04 -2.17% -2.21% 930K

|

Health Technology

| 282.31% | O: 25.32% H: 3.63% C: -8.29%
expansion collaboration technology cardiovascular platform

Tempus Announces Research Collaboration with Bristol Myers Squibb to Apply Multimodal AI Approaches
Published: 2023-11-08 (Crawled : 20:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -7.63% | O: 0.44% H: 0.11% C: -0.19%
research collaboration

SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2023 Financial Results
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -21.19% | O: 0.39% H: 0.33% C: -0.49%
SLS | $1.52 7.8% 6.31% 1.5M

|

Health Technology

| -10.19% | O: -0.64% H: 3.85% C: -0.72%
business life update sciences financial results

Arbutus Appoints Two New Executives
Published: 2023-07-10 (Crawled : 20:00) - globenewswire.com
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -22.7% | O: -0.26% H: 0.96% C: 0.75%
NBRV | $1.42 1.39% 720K

|

Health Technology

| -8.46% | O: 1.85% H: 0.0% C: -4.11%
KRYS | $163.97 -3.34% -3.41% 230K

|

Health Technology

| 37.53% | O: -0.4% H: 0.11% C: -0.1%
ABUS | News | $2.73 -1.8% -1.83% 1M

|

Health Technology

| 21.68% | O: 2.65% H: 0.0% C: -2.16%

Mirati Therapeutics Provides Update on the Phase 3 SAPPHIRE Study Evaluating Sitravatinib in Combination with OPDIVO®
Published: 2023-05-24 (Crawled : 20:00) - prnewswire.com
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -26.23% | O: -0.81% H: 0.32% C: -0.59%
MRTX | $58.7 -0.17% 0.34% 0

|

Health Technology

| 34.17% | O: -6.18% H: 0.0% C: -6.64%
opdivo update sapphire therapeutics study

Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results
Published: 2023-05-10 (Crawled : 20:00) - globenewswire.com
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -29.48% | O: 0.12% H: 0.77% C: 0.74%
SGEN | $228.74 0.1% 20M

|

Health Technology

| 14.38% | O: 0.29% H: 0.22% C: -0.53%
KRON | $1.03 -0.96% -2.97% 210K

|

Health Technology

| -42.54% | O: 1.66% H: 4.35% C: -4.35%
business financial results

Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-05-08 (Crawled : 20:00) - prnewswire.com
TSVT | $4.64 -8.3% -8.82% 620K

|

| -55.22% | O: -0.53% H: 2.31% C: 0.8%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -29.4% | O: -0.6% H: 0.54% C: 0.0%
INBX | $34.45 -0.46% -0.41% 420K

|

Health Technology

| 30.85% | O: -2.76% H: 5.17% C: 2.29%
BLUE | $0.953 -1.07% -0.52% 6.2M

|

Health Technology

| -78.16% | O: -3.22% H: 22.09% C: 16.39%
financial results

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $172.54 -1.41% -19.21% 160

|

| -10.86% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $86.918 -1.19% 3.3% 0

|

| -11.33% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | $138.24 -1.36% -4.19% 800

|

Health Technology

| 3.92% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $541.52 -1.05% -0.1% 1.8M

|

Health Technology

| -4.57% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $12.78 -3.03% -1.8% 8.4M

|

Health Technology

| 33.0% | O: -1.21% H: 0.43% C: -3.58%
TAK | News | $13.16 0.08% 0.53% 1.2M

|

Health Technology

| -15.92% | O: 0.83% H: 0.06% C: -1.2%
PRGO | $29.94 -0.33% -0.6% 970K

|

Health Technology

| -18.72% | O: 0.76% H: 1.91% C: 1.26%
GSK | $39.27 -0.83% 0.26% 1.9M

|

Health Technology

| 14.95% | O: 0.32% H: 0.17% C: -1.53%
LLY | $745.95 -0.64% -0.13% 17K

|

Health Technology

| 135.38% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $55.8 -0.29% 0.0% 1.1M

|

Health Technology

| -21.81% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -29.9% | O: 0.41% H: 0.04% C: -1.71%
ALB | News | $111.8 -2.26% -0.05% 2M

|

Process Industries

| -55.43% | O: -0.95% H: 1.02% C: -2.19%
ABBV | News | $164.66 0.25% -0.14% 3.6M

|

Health Technology

| 6.36% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $45.39 -1.56% -1.58% 4.3M

|

Health Technology

| -4.65% | O: 0.65% H: 0.0% C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 4.9M

|

Health Technology

| -17.52% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $190.52 -0.85% -0.84% 1.3M

|

Health Technology

| -27.79% | O: 0.28% H: 0.0% C: -2.26%
AZN | $68.36 -0.25% -0.25% 3.6M

|

Health Technology

| 5.74% | O: 0.9% H: 0.28% C: -1.3%
global report market

Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published: 2023-01-16 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -7.27% | O: -0.2% H: 0.0% C: 0.0%
PFE A | $25.39 -0.12% 0.24% 31M

|

Health Technology

| -46.88% | O: -2.74% H: 0.43% C: -0.99%
JNJ | News | $145.74 0.67% -0.18% 7M

|

Health Technology

| -16.42% | O: 0.33% H: 0.33% C: -0.94%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -33.39% | O: 0.83% H: 0.52% C: -1.09%
ABT | News | $105.27 -0.6% -0.38% 5.9M

|

Health Technology

| -6.26% | O: -0.01% H: 0.69% C: -0.1%
SNY | News | $45.39 -1.56% -1.58% 4.3M

|

Health Technology

| -7.65% | O: 1.1% H: 0.22% C: 0.02%
GILD | News | $66.16 -1.15% -1.16% 4.9M

|

Health Technology

| -22.45% | O: -0.26% H: 0.37% C: -0.74%
COCP | $1.495 4.55% -1.39% 5.1K

|

Health Technology

| -29.91% | O: 0.47% H: 11.16% C: 7.91%
hepatitis global antiviral hiv therapeutics growth market

Increasing uptake of Biopharmaceuticals is Escalating the Demand for Active Pharmaceutical Ingredients Globally| UnivDatos Market Insights
Published: 2022-09-19 (Crawled : 20:00) - prnewswire.com
VTRS | $11.12 0.18% 0.09% 2.3M

|

Health Technology

| 19.7% | O: -0.64% H: 0.0% C: -2.06%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -31.19% | O: -0.56% H: 0.37% C: -0.1%
ALB | News | $111.8 -2.26% -0.05% 2M

|

Process Industries

| -61.44% | O: -1.2% H: 0.21% C: -1.96%
ABBV | News | $164.66 0.25% -0.14% 3.6M

|

Health Technology

| 15.77% | O: -0.59% H: 0.47% C: -0.04%
active market

Immuno-Oncology Drugs Global Market to Reach $116.23 Billion by 2026
Published: 2022-08-31 (Crawled : 20:00) - prnewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M

|

Health Technology

| -11.17% | O: -0.93% H: 0.0% C: 0.0%
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -28.35% | O: -0.03% H: 2.54% C: 2.52%
AMGN | $262.75 -0.5% -0.49% 1.4M

|

Health Technology

| 10.25% | O: 0.34% H: 1.92% C: 1.82%
global market

Worldwide Natural Killer Cells Therapeutics Industry to 2027 - Featuring Fate Therapeutics, Fortress Biotech and Ziopharm Oncology Among Others
Published: 2022-07-01 (Crawled : 20:00) - prnewswire.com
IPHA | $2.35 -2.49% -0.42% 11K

|

Health Technology

| Email alert Add to watchlist
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| Email alert Add to watchlist
TAK | News | $13.16 0.08% 0.53% 1.2M

|

Health Technology

| Email alert Add to watchlist
biotech therapeutics

Bristol Myers Squibb Presents New Data Showing Effect of Early Zeposia (ozanimod) Treatment in Improving and Preserving Cognitive Function in People With Relapsing Multiple Sclerosis
Published: 2022-06-24 (Crawled : 20:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -37.83% | O: 1.2% H: 0.48% C: 0.43%
treatment sclerosis

New Data Highlight Immune Response to COVID-19 Vaccines in Individuals with Relapsing Forms of Multiple Sclerosis Treated with Zeposia (ozanimod)
Published: 2022-06-24 (Crawled : 20:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -37.83% | O: 1.2% H: 0.48% C: 0.43%
covid-19 response sclerosis

Replimune Reports Fiscal Fourth Quarter and Year-Ended 2022 Financial Results and Provides Corporate Update
Published: 2022-05-19 (Crawled : 20:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M

|

Health Technology

| -38.2% | O: -2.65% H: 0.92% C: -0.17%
SNY | News | $45.39 -1.56% -1.58% 4.3M

|

Health Technology

| -14.74% | O: -1.14% H: 0.0% C: 0.0%
REPL | $6.97 -3.33% -3.3% 1.1M

|

Health Technology

| -49.33% | O: -1.83% H: 5.37% C: 2.93%
results

← Previous
1
2
Next →

Gainers vs Losers

58%

42%

Top 10 Gainers

ZCMD | $1.45 5.84% 49.63% 15M

|

Commercial Services

AULT | $0.2421 -7.7% 45.23% 16M

|

TPET | $0.3279 -3.56% 28.48% 33M

|

TIRX | $0.8 65.02% 25.95% 410K

|

VTNR 4 | $1.31 33.78% 25.82% 220K

|

Industrial Services

GDHG | $0.263 21.76% 25.34% 1.3M

|

HOLO | $2.95 31.7% 22.49% 37M

|

MTNB | $0.19 -1.04% 14.58% 950K

|

Health Technology

UMAC | $1.55 0.65% 12.9% 0

|

TAOP | $1.08 13.01% 11.51% 19K

|

Technology Services

Your saved searches

Save your searches and get alerts when important news are released.